We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Genetic heterogeneity of cardiomyopathy and its correlation with patient care

    Background

    Cardiomyopathy, which is a genetically and phenotypically heterogeneous pathological condition, is associated with increased morbidity and...

    Mi ** Kim, Seulgi Cha, ... Beom Hee Lee in BMC Medical Genomics
    Article Open access 30 October 2023
  2. Regulated cell death pathways in cardiomyopathy

    Heart disease is a worldwide health menace. Both intractable primary and secondary cardiomyopathies contribute to malignant cardiac dysfunction and...

    Shu-yuan Sheng, Jia-min Li, ... Yibin Wang in Acta Pharmacologica Sinica
    Article 13 March 2023
  3. The CREG1-FBXO27-LAMP2 axis alleviates diabetic cardiomyopathy by promoting autophagy in cardiomyocytes

    Autophagy plays an important role in the development of diabetic cardiomyopathy. Cellular repressor of E1A-stimulated genes 1 (CREG1) is an important...

    Dan Liu, Ruinan **ng, ... Yaling Han in Experimental & Molecular Medicine
    Article Open access 01 September 2023
  4. Epigenetics in diabetic cardiomyopathy

    Diabetic cardiomyopathy (DCM) is a critical complication that poses a significant threat to the health of patients with diabetes. The intricate...

    **aozhu Ma, Shuai Mei, ... Jiangtao Yan in Clinical Epigenetics
    Article Open access 05 April 2024
  5. Prmt7 regulates the JAK/STAT/Socs3 signaling pathway in postmenopausal cardiomyopathy

    Protein arginine methyltransferases (PRMTs) modulate diverse cellular processes, including stress responses. The present study explored the role of...

    Byeong-Yun Ahn, Yan Zhang, ... Jong-Sun Kang in Experimental & Molecular Medicine
    Article Open access 14 March 2024
  6. Genetic therapies for cardiomyopathy: survey of attitudes of the patient community for the CureHeart project

    Cardiomyopathies are a group of inherited heart muscle disorders. Expressivity is variable and while sometimes mild, complications can result in...

    Elizabeth Ormondroyd, Christopher Grace, ... Hugh Watkins in European Journal of Human Genetics
    Article Open access 07 July 2024
  7. Genome Editing and Diabetic Cardiomyopathy

    Differential gene expression is associated with diabetic cardiomyopathy (DMCM) and culminates in adverse remodeling in the diabetic heart. Genome...
    Tyler N. Kambis, Paras K. Mishra in Genome Editing in Cardiovascular and Metabolic Diseases
    Chapter 2023
  8. Surveillance after childhood cancer: are survivors with an increased risk for cardiomyopathy regularly followed-up?

    Background

    We aimed to study adherence to cardiac screening in long-term childhood cancer survivors (CCS) at high risk of cardiomyopathy.

    ...
    Nicolas Bougas, Rodrigue S. Allodji, ... Agnès Dumas in British Journal of Cancer
    Article 21 August 2023
  9. Pediatric hypertrophic cardiomyopathy caused by a novel TNNI3 variant

    TNNI3 is a gene that causes hypertrophic cardiomyopathy (HCM). A 14-year-old girl who was diagnosed with nonobstructive HCM presented with...

    Natsuko Inagaki, Tomoya Okano, ... Kazuhiro Satomi in Human Genome Variation
    Article Open access 29 March 2024
  10. Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy

    Metabolic cardiomyopathy is an emerging cause of heart failure in patients with obesity, insulin resistance, and diabetes. It is characterized by...

    Ze Chen, Zhao-**a **, ... Hongliang Li in Journal of Molecular Medicine
    Article 17 November 2022
  11. Intermittent Hypoxic Preconditioning Plays a Cardioprotective Role in Doxorubicin-Induced Cardiomyopathy

    Intermittent hypoxic preconditioning (IHP) is a well-established cardioprotective intervention in models of ischemia/reperfusion injury....

    Peter Galis, Linda Bartosova, ... Tomas Rajtik in Cardiovascular Toxicology
    Article 29 April 2023
  12. Diabetic Cardiomyopathy and Cell Death: Focus on Metal-Mediated Cell Death

    Cardiac myocyte death is an essential initiator of the pathogenesis and progression of various etiological cardiomyopathies, including diabetic...

    Lu Cai, Yi Tan, ... Kupper Wintergerst in Cardiovascular Toxicology
    Article 06 February 2024
  13. Epigenetics of Cardiomyopathy: Histone Modifications and DNA Methylation

    Abstract

    Cardiomyopathies are an actively investigated clinically and genetically heterogeneous group of myocardial pathologies. At present, it is...

    A. N. Kucher, M. S. Nazarenko in Russian Journal of Genetics
    Article 01 March 2023
  14. Novel insights into the role of mitochondria in diabetic cardiomyopathy: molecular mechanisms and potential treatments

    Diabetic cardiomyopathy describes decreased myocardial function in diabetic patients in the absence of other heart diseases such as myocardial...

    Fumin Zhi, Qian Zhang, ... Hongtao Xu in Cell Stress and Chaperones
    Article 05 July 2023
  15. The Scope of Mendelian Cardiomyopathy Genes

    Abstract

    The review analyses the scope of the genes of Mendelian cardiomyopathies (CM), specifically hypertrophic, dilated, arrhythmogenic, and...

    A. N. Kucher, M. S. Nazarenko in Russian Journal of Genetics
    Article 01 January 2024
  16. Renin Angiotensin System in the Pathophysiology of Diabetic Cardiomyopathy in Type 2 Diabetes

    Type 2 diabetesDiabetes mellitus is associated with a high risk of heart failureHeart failure, in part because of its potential to induce impaired...
    Karina P. Gomes, Anshul S. Jadli, Vaibhav B. Patel in The Renin Angiotensin System in Cardiovascular Disease
    Chapter 2023
  17. Never in mitosis gene A-related kinase-6 deficiency deteriorates diabetic cardiomyopathy via regulating heat shock protein 72

    Abstract

    NIMA (never in mitosis, gene A)-related kinase-6 (NEK6), a cell cycle regulatory gene, was found to regulate cardiac hypertrophy. However,...

    Shuangyin Shao, Lili **ao, ... Lu Gao in Journal of Molecular Medicine
    Article 03 March 2023
  18. Macrod1 suppresses diabetic cardiomyopathy via regulating PARP1-NAD+-SIRT3 pathway

    Diabetic cardiomyopathy (DCM), one of the most serious long-term consequences of diabetes, is closely associated with oxidative stress, inflammation...

    Yu-ting Liu, Hong-liang Qiu, ... Qi-zhu Tang in Acta Pharmacologica Sinica
    Article 08 March 2024
Did you find what you were looking for? Share feedback.